Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Barclays analyst Andrew Mok maintains Oscar Health (NYSE:OSCR) with a Underweight and raises the price target from $11 to $13.
Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, today is introducing affordable, tec...
UBS analyst Jonathan Yong maintains Oscar Health (NYSE:OSCR) with a Sell and raises the price target from $11 to $12.
New Leverage Shares ETFs allow investors double daily returns on Lululemon, Gemini, and Oscar Health at one of the lowest fees ...
Oscar Health's Q3 revenue rose to $2.99 billion on higher membership, but losses widened as risk adjustments offset gains.
After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading...
